"Appropriate regulatory framework, aided with proper government policies could help the industry grow to a USD 25-30 billion in the next ten years," AdvaMed India Working Group Chair Sanjay Banerji told reporters here.
Currently, the size of medical device industry in India is estimated to be around USD 4 billion and represents just 7-8 per cent of the total healthcare industry, he added.
AdvaMed is an association of medical devices makers representing 80 per cent of medical technology firms in the US and its member companies produce more than 40 per cent of medical devices used annually around the world.
Elaborating on the regulatory framework, Banerji said the recently released Draft of Drugs and Cosmetics (Amendment ) Bill, 2015 addresses several of the industry's challenges.
"It (bill) is a big leap forward for healthcare delivery and allied sectors in India. This is particularly so in case of the medical devices industry which for the first time has been accorded a distinct status and definition in the bill, he added.
Currently, 14 categories of medical devices and eight additional products are regulated as drugs under the Drugs and Cosmetics Act, 1940.
Besides, the industry is hoping that issues like risk based classification, separate chapter for clinical trials and separate regulatory entities for the medical devices sector would find space in the new Drugs and Cosmetics (Amendment) Bill, he added.
AdvaMed also asked the government to create an ecosystem for the growth of the sector, including allocation of funds for medical technology (medtech) parks in the country.
Besides, it also advocated for reduction in the duty on life saving medical devices.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
